Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Frontiers in Bioscience (Landmark Edition)|May 31, 2011
RAS and Hedgehog--partners in crimeMatthias LauthCurrent Opinion in Investigational Drugs (London, England : 2000)|July 12, 2007
The Hedgehog pathway as a drug target in cancer therapyMatthias Lauth, Rune ToftgårdAdvances in Cancer Research|June 28, 2011
Hedgehog signaling and pancreatic tumor developmentMatthias Lauth, Rune ToftgårdJournal of Developmental Biology|April 5, 2018
Emerging Roles of DYRK Kinases in Embryogenesis and Hedgehog Pathway ControlRajeev Singh, Matthias LauthCell Cycle (Georgetown, Tex.)|August 30, 2007
Non-canonical activation of GLI transcription factors: implications for targeted anti-cancer therapyMatthias Lauth, Rune ToftgårdExpert Opinion on Therapeutic Targets|August 1, 2014
The role of pancreatic and duodenal homeobox 1 as a therapeutic target in pancreatic cancerVolker Fendrich, Matthias LauthDevelopmental Cell|October 15, 2014
Think inside the BOCs: a mechanism underlying medulloblastoma progressionMatthias Lauth, Rune ToftgardOncogene|January 25, 2025
A safe haven for cancer cells: tumor plus stroma control by DYRK1BMiriam Ems, Anna Brichkina, Matthias LauthCerebellum (London, England)|July 29, 2003
Genetic targeting of cerebellar Purkinje cells: history, current status and novel strategiesJaroslaw J Barski, Matthias Lauth, Michael MeyerOncotarget|December 2, 2016
DYRK1B blocks canonical and promotes non-canonical Hedgehog signaling through activation of the mTOR/AKT pathwayRajeev Singh, Pavan Kumar Dhanyamraju, Matthias LauthPageof 6